Researchers reported findings that implicate epidermal MHC class II in coordinating NK-cell recruitment in psoriasis, with downstream effects involving pyroptosis in keratinocytes. The study is described as revealing an immunologic pathway that contributes to psoriasis pathogenesis. The article says epidermal MHC-II molecules help recruit NK cells to the skin, triggering inflammatory programmed cell death of keratinocytes through pyroptosis. The mechanism is framed as a driver of disease progression rather than a secondary marker. The work suggests psoriasis biology may hinge on localized antigen presentation signals within the epidermis that shape innate immune cell behavior. For drug development, the findings point toward intervention points in the MHC-II–NK axis and may inform target selection for next-generation psoriasis immunotherapies.